Perfil
Aurelien Valet is the founder of Graftys SA and Biologics 4 Life SAS.
At Graftys SA, he holds the title of Director & Deputy Chief Executive Officer starting in 2005.
At Biologics 4 Life SAS, he held the title of President from 2018 to 2021.
Cargos activos de Aurelien Valet
| Empresas | Cargo | Inicio |
|---|---|---|
Graftys SA
 Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Fundador | 01/09/2005 |
Antiguos cargos conocidos de Aurelien Valet.
| Empresas | Cargo | Fin |
|---|---|---|
Biologics 4 Life SAS
 Biologics 4 Life SAS Pharmaceuticals: MajorHealth Technology Part of Graftys SA, Biologics 4 Life SAS develops injectable biomaterials to treat and prevent fractures caused by osteoporosis. The company is based in Jouques, France. The French company was founded in 2018 by Aurelien Valet, Alain Valet, Sébastien Genesta. Biologics 4 Life was acquired by Graftys SA on November 08, 2021. | Fundador | 01/11/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
Biologics 4 Life SAS
Biologics 4 Life SAS Pharmaceuticals: MajorHealth Technology Part of Graftys SA, Biologics 4 Life SAS develops injectable biomaterials to treat and prevent fractures caused by osteoporosis. The company is based in Jouques, France. The French company was founded in 2018 by Aurelien Valet, Alain Valet, Sébastien Genesta. Biologics 4 Life was acquired by Graftys SA on November 08, 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Aurelien Valet
